Democratic Republic of Congo


In the Democratic Republic of Congo (DRC), HIV is the fifth leading cause of death. In the Democratic Republic of Congo (DRC), HIV is the fifth leading cause of death. Of the 370,000 people living with HIV in the DRC, only 29% of adults were receiving antiretroviral therapy (ART) as of 2016.
Download Country Fact Sheet

Key Program Accomplishments

Since 2001, EGPAF-DRC has:

Increased the number of health facilities offering antiretroviral treatment (ART) services from 23 to 121

Provided over 980,000 pregnant women with access to critical PMTCT services

Enrolled almost 16,000 people on ART; including over 1,500 children

Averted nearly 2,500 HIV infections

Supported over 130 sites across the Kinshasa Province

Our Work

The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) began supporting critical HIV and AIDS services in the DRC in 2001, providing funding and technical assistance to prevention of mother-to-child HIV transmission (PMTCT) programs implemented by the Kinshasa School of Public Health and the University of North Carolina. Since 2001, EGPAF has implemented and scaled up access to HIV testing and counseling, early infant HIV diagnosis (EID), adult and pediatric HIV care and treatment, tuberculosis (TB) and HIV co-infection management, sexually transmitted infection identification and treatment, and sexual and gender-based violence care services.

EGPAF is currently supporting 134 sites across the Kinshasa province. EGPAF works alongside communities, religious leaders and health zones of which these clinics serve to ensure promotion of PMTCT and adult and pediatric HIV testing, care and treatment.

As an implementing partner to DRC’s Ministry of Health, EGPAF provides targeted assistance to the National AIDS Control Program. This assistance has entailed updating country PMTCT and HIV care and treatment guidelines to reflect current World Health Organization (WHO) guidelines, with technical assistance support at both province- and site-level to ensure implementation of revised guidelines. EGPAF is currently supporting adoption of the new WHO recommendations (“Treatment for All”) through its participation in pediatric and adult care and treatment national technical working groups.

In addition to EGPAF’s direct support in provision of health services and advocacy for improved local policies, EGPAF is dedicated to advancing clinical and operations research to improve HIV prevention and care and treatment of HIV and AIDS. Through funding from Dance Marathon at UCLA, EGPAF recently conducted a study on male involvement to evaluate how better to engage men in antenatal and maternity services, including HIV testing. The study offered an opportunity to inform national scale-up of best practices.